1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation
    Meeting Abstract

    Glassman, D. C.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Effect of ASXL1 on the stemness of colorectal cancer initiating cells
    Meeting Abstract

    Isobe, T.; Zarnegar, M. A.; Abdel-Wahab, O. I.; Clarke, M. F.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study
    Meeting Abstract

    Bekaii-Saab, T. S.; Ou, F. S.; Anderson, D. M.; Ahn, D. H.; Boland, P. M.; Ciombor, K. K.; Jacobs, N. L.; Desnoyers, R. J.; Cleary, J. M.; Meyers, J. P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • HALO 110-101: A phase Ib, randomized, open-label study of PEGPH20 (pegvorhyaluronidase alfa) in combination with cisplatin (CIS) + gemcitabine (GEM) (PEGCISGEM) or atezolizumab and CIS + GEM (PEGCISGEMATEZO) in hyaluronan-high subjects with locally advanced or metastatic cholangiocarcinoma and gallbladder cancer
    Meeting Abstract

    Borad, M. J.; Shroff, R. T.; Abou-Alfa, G. K.; Hecht, J. R.; Bullock, A. J.; Ritch, P. S.; Chondros, D.; Muhsin, M.; Oh, D. Y.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nivolumab safety profile in Asian and Western patients with chemotherapy-refractory (CTx-R) advanced gastric/gastroesophageal junction (adv G/GEJ) cancer from the ATTRACTION-2 and CheckMate-032 trials
    Meeting Abstract

    Chau, I.; Chen, L. T.; Kang, Y. K.; Satoh, T.; Kato, K.; Chung, H. C.; Kang, W. K.; Chao, Y.; Chen, J. S.; Ott, P. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • The prognostic value of systemic inflammation in patients undergoing surgery for rectal cancer: Comparison of composite ratios and cumulative scores
    Meeting Abstract

    Dolan, R.; McSorley, S. T.; Park, J. H.; Roxburgh, C. S. D.; Horgan, P. G.; McMillan, D. C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Associations of incidence of common adverse events (AEs) and survival outcomes in metastatic colorectal cancer (mCRC) patients (pts) treated with first line chemotherapy: Findings from 9,812 pts in the ARCAD database
    Meeting Abstract

    Ferraro, D. A.; Zalcberg, J. R.; Shi, Q.; Meyers, J. P.; Seymour, M. T.; Saltz, L.; Maughan, T.; Goldberg, R. M.; Van Cutsem, E.; Heinemann, V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Effect of tumor progression on colon cancer stem cell plasticity
    Meeting Abstract

    Chiu, V. K.; Gallupalli, R.; Osman, D.; Zeng, Z.; Shia, J.; Paty, P.; Le Rolle, A. F.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Blood-induced bone loss in a mouse model of hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNFα pathway
    Meeting Abstract

    Haxaire, C.; Hakobyan, N.; Panellini, T.; Carballo, C.; McIlwain, D.; Mak, T. W.; Acharya, S.; Li, D.; Szymonifka, J.; Rodeo, S.; more...
    Journal of Bone and Mineral Research (2018)

    Fulltext@MSK | Save
  • Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia (BFORE Trial): 24-month efficacy update and results by 3-month BCR-ABL1 transcript levels
    Meeting Abstract

    Gambacorti-Passerini, C.; Brummendorf, T. H.; Abruzzese, E.; Rambaldi, A.; Ciceri, F.; Martino, B.; Hochhaus, A.; Deininger, M. W.; Mauro, M. J.; Chuah, C.; more...
    Haematologica (2018)

    Fulltext@MSK | Save